APA (7th ed.) Citation

IM, M., M, K., K, O., M, F., PL, F., A, F., . . . A, K. (2021). Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest). Annals of surgical oncology, 28(12), 7506. https://doi.org/10.1245/s10434-021-10021-1

Chicago Style (17th ed.) Citation

IM, Modlin, et al. "Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic MRNA Signature (NETest)." Annals of Surgical Oncology 28, no. 12 (2021): 7506. https://doi.org/10.1245/s10434-021-10021-1.

MLA (9th ed.) Citation

IM, Modlin, et al. "Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic MRNA Signature (NETest)." Annals of Surgical Oncology, vol. 28, no. 12, 2021, p. 7506, https://doi.org/10.1245/s10434-021-10021-1.